Cargando…

Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer

Breast cancer is one of the most deadly forms of cancer in women worldwide. Better prediction of breast cancer prognosis is essential for more personalized treatment. In this study, we aimed to infer patient‐specific subpathway activities to reveal a functional signature associated with the prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Junwei, Liu, Siyao, Jiang, Ying, Xu, Chaohan, Zheng, Baotong, Jiang, Minghao, Yang, Haixiu, Su, Fei, Li, Chunquan, Zhang, Yunpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111825/
https://www.ncbi.nlm.nih.gov/pubmed/29971923
http://dx.doi.org/10.1111/jcmm.13720
_version_ 1783350739964264448
author Han, Junwei
Liu, Siyao
Jiang, Ying
Xu, Chaohan
Zheng, Baotong
Jiang, Minghao
Yang, Haixiu
Su, Fei
Li, Chunquan
Zhang, Yunpeng
author_facet Han, Junwei
Liu, Siyao
Jiang, Ying
Xu, Chaohan
Zheng, Baotong
Jiang, Minghao
Yang, Haixiu
Su, Fei
Li, Chunquan
Zhang, Yunpeng
author_sort Han, Junwei
collection PubMed
description Breast cancer is one of the most deadly forms of cancer in women worldwide. Better prediction of breast cancer prognosis is essential for more personalized treatment. In this study, we aimed to infer patient‐specific subpathway activities to reveal a functional signature associated with the prognosis of patients with breast cancer. We integrated pathway structure with gene expression data to construct patient‐specific subpathway activity profiles using a greedy search algorithm. A four‐subpathway prognostic signature was developed in the training set using a random forest supervised classification algorithm and a prognostic score model with the activity profiles. According to the signature, patients were classified into high‐risk and low‐risk groups with significantly different overall survival in the training set (median survival of 65 vs 106 months, P = 1.82e‐13) and test set (median survival of 75 vs 101 months, P = 4.17e‐5). Our signature was then applied to five independent breast cancer data sets and showed similar prognostic values, confirming the accuracy and robustness of the subpathway signature. Stratified analysis suggested that the four‐subpathway signature had prognostic value within subtypes of breast cancer. Our results suggest that the four‐subpathway signature may be a useful biomarker for breast cancer prognosis.
format Online
Article
Text
id pubmed-6111825
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61118252018-09-01 Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer Han, Junwei Liu, Siyao Jiang, Ying Xu, Chaohan Zheng, Baotong Jiang, Minghao Yang, Haixiu Su, Fei Li, Chunquan Zhang, Yunpeng J Cell Mol Med Original Articles Breast cancer is one of the most deadly forms of cancer in women worldwide. Better prediction of breast cancer prognosis is essential for more personalized treatment. In this study, we aimed to infer patient‐specific subpathway activities to reveal a functional signature associated with the prognosis of patients with breast cancer. We integrated pathway structure with gene expression data to construct patient‐specific subpathway activity profiles using a greedy search algorithm. A four‐subpathway prognostic signature was developed in the training set using a random forest supervised classification algorithm and a prognostic score model with the activity profiles. According to the signature, patients were classified into high‐risk and low‐risk groups with significantly different overall survival in the training set (median survival of 65 vs 106 months, P = 1.82e‐13) and test set (median survival of 75 vs 101 months, P = 4.17e‐5). Our signature was then applied to five independent breast cancer data sets and showed similar prognostic values, confirming the accuracy and robustness of the subpathway signature. Stratified analysis suggested that the four‐subpathway signature had prognostic value within subtypes of breast cancer. Our results suggest that the four‐subpathway signature may be a useful biomarker for breast cancer prognosis. John Wiley and Sons Inc. 2018-07-04 2018-09 /pmc/articles/PMC6111825/ /pubmed/29971923 http://dx.doi.org/10.1111/jcmm.13720 Text en © 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Han, Junwei
Liu, Siyao
Jiang, Ying
Xu, Chaohan
Zheng, Baotong
Jiang, Minghao
Yang, Haixiu
Su, Fei
Li, Chunquan
Zhang, Yunpeng
Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
title Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
title_full Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
title_fullStr Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
title_full_unstemmed Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
title_short Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
title_sort inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111825/
https://www.ncbi.nlm.nih.gov/pubmed/29971923
http://dx.doi.org/10.1111/jcmm.13720
work_keys_str_mv AT hanjunwei inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer
AT liusiyao inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer
AT jiangying inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer
AT xuchaohan inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer
AT zhengbaotong inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer
AT jiangminghao inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer
AT yanghaixiu inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer
AT sufei inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer
AT lichunquan inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer
AT zhangyunpeng inferenceofpatientspecificsubpathwayactivitiesrevealsafunctionalsignatureassociatedwiththeprognosisofpatientswithbreastcancer